Clinical Trials
4 trialsNCT05007106 2025-08-14
KEYVIBE-005
Merck Sharp & Dohme LLC
Phase 2 Completed
NCT03314935 2025-08-12
A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors
Incyte Corporation
Phase 1/2 Completed
NCT00071929 2013-06-24
Oxaliplatin in Treating Patients With Persistent or Recurrent Endometrial Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00612495 2008-02-11
Endometrial Cancer - LOHP Alone and With 5FU
Sanofi
Phase 2 Completed